메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
ObjectiveIsotretinoin is a notorious teratogen otherwise used for the treatment of acne vulgaris. Some countries, includingthose in North America and the European Union, implemented the pregnancy prevention program (PPP); however,no PPP has yet been established in South Korea. So the aim of this study was to evaluate the rate of pregnant womenexposed to isotretinoin among the callers of the Korean Mother Safe Counseling Center. MethodsThis is a prospective cohort study. We evaluated the demographic characteristics, obstetric history, and isotretinoinexposure of pregnant women based on the mother safe registry from April 2010 to July 2016. ResultsAmong 22,374 callers, 650 (2.9%) pregnant women were exposed to isotretinoin. The mean age was 29.0±4.4 yearsin the isotretinoin-exposed group and 32.0±4.2 years in the unexposed group (P<0.001). Moreover, the incidence ofpregnancies within 30 days after isotretinoin discontinuation or during isotretinoin intake was 78.9% (513/650). Themedian duration of isotretinoin exposure was 18 (1–4,231) days. Furthermore, from 2011 to 2015, the incidence ofisotretinoin exposure was 2.9±1.2 pregnancies per 10,000 births in South Korea. ConclusionApproximately 80% of pregnant women are exposed to isotretinoin within the recommended 30 days ofcontraception or during pregnancy. Therefore, the PPP has to be established in South Korea.

목차

등록된 정보가 없습니다.

참고문헌 (19)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0